METTL3 and cancer: As a result, we found that METTL3 deficiency may also sensitize HNSCC cells to cisplatin by more effective cell cycle arrest, apoptosis induction, and inhibition of colony formation and, in contrast, increased the expression of cancer stem cell markers.